The "A 215" imprint is listed in published drug labeling as oxycodone hydrochloride 30 mg. Here is what the imprint means, what it cannot tell you, and why counterfeit blue tablets have become a serious safety concern on Long Island and across New York.

Every prescription tablet sold in the United States must carry a unique identifying code. That code, combined with shape and color, lets pharmacists and clinicians confirm which product they are handling. In published drug labeling and pill identification references, a round light-blue tablet marked "A 215" is listed as oxycodone hydrochloride 30 mg in an immediate-release form.
Oxycodone is a prescription opioid used for pain that a clinician judges severe enough to require an opioid. It is a Schedule II controlled substance, meaning federal law recognizes an accepted medical use alongside a high potential for misuse and dependence.
| Attribute | Listed value |
|---|---|
| Imprint | A 215 |
| Active ingredient | Oxycodone hydrochloride 30 mg |
| Drug class | Opioid analgesic |
| Appearance | Round, light blue, scored |
| Controlled substance schedule | Schedule II (prescription only) |
Much of the current search interest in imprints like A215 comes from tablets found loose, in a bag, or passed between people rather than dispensed by a pharmacy. That is where the picture changes.
The U.S. Drug Enforcement Administration reports that counterfeit tablets pressed to resemble prescription medication are widely circulated, and that a substantial share of the counterfeits it has tested contain illicit fentanyl. Because illegal presses copy color, shape, scoring, and imprint, a counterfeit can be visually indistinguishable from a pharmacy tablet.
Counterfeits are also inconsistent. Two tablets from the same batch can contain very different amounts of fentanyl, which is why people who have used a substance before can still experience an overdose without warning.

Pill identification tools match three features: the imprint code, the shape, and the color. Together these usually point to a single registered product, which is useful for confirming a prescription refill or checking that a pharmacy tablet looks like the last one.
What identification cannot do is verify authenticity. Databases describe legitimate products; they cannot inspect the tablet in front of you. If a tablet came from anywhere other than a licensed pharmacy, treat its contents as unknown regardless of how convincing the imprint looks.
If you have a question about a tablet found at home, a pharmacist can help you identify a dispensed medication, and unused medication can be surrendered at police-run drug take-back boxes throughout Nassau and Suffolk Counties.
Overdose involving opioids slows or stops breathing. Common signs include unresponsiveness, very slow or absent breathing, gurgling or snoring sounds, pinpoint pupils, and blue or gray lips, fingertips, or skin.

Regular opioid use can lead to tolerance and physical dependence, and for some people to opioid use disorder. Dependence can develop even with prescribed use, which is why stopping abruptly often feels harder than people expect.
Opioid withdrawal commonly brings restlessness, muscle aches, sweating, chills, stomach cramps, nausea, insomnia, and strong cravings. It is usually not life threatening by itself, but it can be severe, and returning to previous use after a period of abstinence raises overdose risk because tolerance drops.
Evidence-based options include medically supervised withdrawal, medication for opioid use disorder such as buprenorphine or methadone, outpatient and intensive outpatient counseling, and inpatient rehabilitation. Research consistently finds that medication combined with counseling produces better outcomes than counseling alone for opioid use disorder.
Nassau and Suffolk Counties have been affected by the shift from prescription opioids to illicit fentanyl, and both counties run opioid overdose prevention programs that provide naloxone training and kits at no cost to residents.
Treatment programs across Long Island are certified by the New York State Office of Addiction Services and Supports (OASAS), which publishes a public directory and a treatment availability dashboard showing open beds and program types.
Imprint information reflects published manufacturer labeling. Manufacturers can discontinue or revise products, so an imprint listing should be treated as a reference point rather than proof of what a tablet contains.
Estimates of how many counterfeit tablets contain fentanyl come from law enforcement seizure testing, which samples what is intercepted rather than everything in circulation. The broad finding — that counterfeit tablets frequently contain fentanyl and vary widely in content — is well supported, while precise percentages shift between reporting periods.
Get answers to common questions about our 24/7 crisis helpline and addiction support services.
Still have questions? Our crisis counselors are available 24/7.
Call 844-338-6969This page contains information sourced from peer-reviewed medical literature, federal health agencies, and accredited medical institutions to ensure accuracy and compliance with E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) standards.
The information provided on this page is for educational purposes only and should not be considered medical advice. This page does not provide medical diagnoses, treatment prescriptions, or clinical recommendations. Always consult with qualified healthcare professionals for diagnosis and treatment of substance use disorders. If you are experiencing a medical emergency, call 911 immediately.
This content was written by certified addiction professionals and reviewed by licensed medical practitioners to ensure accuracy and adherence to current clinical guidelines. Last fact-checked: August 21, 2026.
If you or someone you know is struggling with substance use, you can reach our 24/7 confidential Long Island Rehab Helpline at 844-338-6969 for free, confidential information and treatment referral.
Compare MAT medications and providers on Long Island
Daily buprenorphine/naloxone for opioid use disorder
Weekly or monthly extended-release buprenorphine injection
Learn how medication-assisted treatment works